Pharmacist Training Program for Long-Acting Injectables

Pharmacist Training Program for Long-Acting Injectables is organized by Ohio Pharmacists Association (OPA) and will be held on Jan 16, 2025 at Ohio Pharmacists Association, Columbus, Ohio, United States of America.

Goals: 
The goals of this program are to train pharmacists in the use of long-acting injectable (LAI) antipsychotics and opioid antagonists; train pharmacists to properly administer these medications; provide strategies for practice implementation; and review the tests necessary prior to administration of an opioid antagonist and evaluation of the test results. Participants must demonstrate proper sterile technique and administration of both IM and SC injections during the program.

Objectives: 
At the conclusion of this activity, participants will be able to:
1. list the FDA-approved indications for long-acting injectable (LAI) antipsychotics and naltrexone;
2. describe the mechanism of action, appropriate dose, contraindications, warnings, and adverse reactions of LAI antipsychotics and naltrexone;
3. discuss appropriate patient populations and the importance of ensuring patient privacy during administration of LAI antipsychotics and naltrexone;
4. compare and contrast LAI antipsychotics by dose, frequency, administration, and requirement for oral supplementation;
5. describe the evidence for naltrexone LAI in treating opioid dependence;
6. compare the efficacy of naltrexone LAI to buprenorphine and methadone for treating opioid and alcohol dependence;
7. evaluate and document the appropriate tests prior to the administration of naltrexone LAI;
8. outline acute and chronic monitoring parameters and treatment of the patient for adverse reactions for each of these dangerous drugs, including use of diphenhydramine and epinephrine;
9. demonstrate proper sterile technique in injectable dosage preparation and administration of intramuscular and subcutaneous injections;
10. explain the proper disposal procedures for contaminated needles and dangerous drugs, and the proper procedures for accidental needle sticks; and
11. discuss practice implementation strategies